Clinical Trials Directory

Trials / Completed

CompletedNCT05506098

Investigating STAT3 as a Driver of Pathology in Periodontitis

Investigating STAT3 as a Driver of Pathology and Potential Therapeutic Target in Periodontitis

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
University of Chile · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Periodontitis is a prevalent inflammatory condition that destroys tooth-supporting structures. This condition is associated with pro-inflammatory mediators that utilize STAT3 as an activator of specific genes related to inflammation and tissue destruction. STAT3 has not been studied in the context of periodontitis in humans. We propose that STAT3 is associated with periodontitis. This knowledge might help to further our understanding of periodontitis pathology

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2019-03-20
Primary completion
2022-10-20
Completion
2022-10-20
First posted
2022-08-18
Last updated
2023-01-30

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT05506098. Inclusion in this directory is not an endorsement.

Investigating STAT3 as a Driver of Pathology in Periodontitis (NCT05506098) · Clinical Trials Directory